392 Targeted gene addition in human CD34+ hematopoietic cells for correction of X-linked chronic granulomatous disease.
http://www.nature.com/nbt/journal/v34/n4/abs/nbt.3513.html
391 Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells.
http://www.nature.com/nature/journal/v532/n7600/full/nature17665.html
390 PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells.
http://www.pnas.org/content/113/16/E2306.abstract
389 Distinct bone marrow blood vessels differentially regulate haematopoiesis.
http://www.nature.com/nature/journal/v532/n7599/full/nature17624.html
388 Modulation of tissue repair by regeneration enhancer elements.
http://www.nature.com/nature/journal/v532/n7598/full/nature17644.html
387 A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells.
http://www.nature.com/ncomms/2016/160411/ncomms11247/full/ncomms11247.html
386 Large-scale production of megakaryocytes from human pluripotent stem cells by chemically defined forward programming.
http://www.nature.com/ncomms/2016/160407/ncomms11208/full/ncomms11208.html
385 When encapsulated with alginate derivatives that resist the foreign-body response, human embryonic stem cell–derived beta cells restore long-term normoglycemia in immunocompetent mice without the need for immunosuppression.
http://www.nature.com/nm/journal/v22/n3/abs/nm.4030.html
384 Nanotopography Promotes Pancreatic Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells.
http://pubs.acs.org/doi/abs/10.1021/acsnano.5b06985
383 Co-ordinated ocular development from human iPS cells and recovery of corneal function.
http://www.nature.com/nature/journal/v531/n7594/full/nature17000.html
|